Submitted by Anonymous (not verified) on 25 July 2024 - 11:50
Human medicines European public assessment report (EPAR): Nulibry, fosdenopterin, Date of authorisation: 15/09/2022, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nulibry, fosdenopterin, Date of authorisation: 15/09/2022, Revision: 3, Status: Authorised